BDTX - Black Diamond Therapeutics GAAP EPS of -$0.57 beats by $0.04

2023-05-09 08:46:45 ET

• Black Diamond Therapeutics press release ( NASDAQ: BDTX ): Q1 GAAP EPS of -$0.57 beats by $0.04 .
• Net Loss: Net loss for the first quarter of 2023 was $20.9 million, as compared to $25.5 million for the same period in 2022.
• Financial Guidance
• Black Diamond ended the first quarter of 2023 with approximately $103.4 million in cash, cash equivalents and investments, which the Company believes is sufficient to fund its anticipated operating expenses and capital expenditure requirements into the third quarter of 2024.

For further details see: